Orris

Why it’s needed to maintain concentration of ors as per blood osmolarity

Reading File
Finding Sources
Finding Sources
Searching PubMed

oral rehydration solution osmolarity intestinal absorption

Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Searching Images

SGLT1 sodium glucose cotransporter intestinal absorption oral rehydration

This composite educational graphic details the physiological absorption and distribution of orally delivered glucose PET tracers (Me-4FDG, 2-FDG, and 4-FDG) in wild-type and Glut2−/− mouse models. Section A displays volumetric renderings of co-registered microPET and CT scans, utilizing the NIH intensity scale (red: highest; purple: lowest). Key landmarks include the brain (br), stomach (st), intestine (in), kidneys (lk/rk), and bladder (bl). The images demonstrate differential organ uptake based on tracer substrate specificity: Me-4FDG (SGLT1 selective) shows high gastric retention and minimal brain uptake, while 2-FDG and 4-FDG (GLUT selective) exhibit notable accumulation in the brain and urinary bladder. Section B provides scatter plots showing the percentage of gastric emptying at 60 minutes, revealing high variability (range 15–100%) but no significant difference between genotypes. Section C quantifies intestinal tracer absorption, showing nearly complete absorption for Me-4FDG and 4-FDG, with slightly lower and more variable absorption for 2-FDG. This figure is used in metabolic research to study the roles of SGLT1 and GLUT2 transporters in intestinal glucose absorption.

This composite educational graphic details the physiological absorption and distribution of orally delivered glucose PET tracers (Me-4FDG, 2-FDG, and 4-FDG) in wild-type and Glut2−/− mouse models. Section A displays volumetric renderings of co-registered microPET and CT scans, utilizing the NIH intensity scale (red: highest; purple: lowest). Key landmarks include the brain (br), stomach (st), intestine (in), kidneys (lk/rk), and bladder (bl). The images demonstrate differential organ uptake based on tracer substrate specificity: Me-4FDG (SGLT1 selective) shows high gastric retention and minimal brain uptake, while 2-FDG and 4-FDG (GLUT selective) exhibit notable accumulation in the brain and urinary bladder. Section B provides scatter plots showing the percentage of gastric emptying at 60 minutes, revealing high variability (range 15–100%) but no significant difference between genotypes. Section C quantifies intestinal tracer absorption, showing nearly complete absorption for Me-4FDG and 4-FDG, with slightly lower and more variable absorption for 2-FDG. This figure is used in metabolic research to study the roles of SGLT1 and GLUT2 transporters in intestinal glucose absorption.

This diagnostic image set illustrates the pharmacokinetics and biodistribution of 4-FDG (4-fluorodeoxyglucose) in a mouse model using PET-CT imaging. Panel A displays volumetric renderings of whole-body PET-CT scans at 20, 35, and 65 minutes post-oral gavage. The top row (Control) shows high tracer intensity primarily in the stomach (st) at early time points, with minimal excretion. The bottom row (Phlorizin-treated) demonstrates the effect of SGLT1/SGLT2 inhibition, characterized by visible tracer in the intestine (in) and significantly earlier and higher accumulation in the urinary bladder (bl). An NIH color scale indicates activity intensity from red (highest) to purple (lowest). Panel B provides a quantitative comparison of gastrointestinal absorption over time, showing a significant initial delay in the phlorizin group at 20 and 35 minutes, which converges by 65 minutes. Panel C quantifies renal excretion, highlighting that phlorizin treatment leads to a marked increase in the percentage of the tracer excreted into the bladder (reaching ~35% at 65 min) compared to control (~7%). These visuals demonstrate the role of SGLTs in intestinal glucose absorption and renal reabsorption.

This diagnostic image set illustrates the pharmacokinetics and biodistribution of 4-FDG (4-fluorodeoxyglucose) in a mouse model using PET-CT imaging. Panel A displays volumetric renderings of whole-body PET-CT scans at 20, 35, and 65 minutes post-oral gavage. The top row (Control) shows high tracer intensity primarily in the stomach (st) at early time points, with minimal excretion. The bottom row (Phlorizin-treated) demonstrates the effect of SGLT1/SGLT2 inhibition, characterized by visible tracer in the intestine (in) and significantly earlier and higher accumulation in the urinary bladder (bl). An NIH color scale indicates activity intensity from red (highest) to purple (lowest). Panel B provides a quantitative comparison of gastrointestinal absorption over time, showing a significant initial delay in the phlorizin group at 20 and 35 minutes, which converges by 65 minutes. Panel C quantifies renal excretion, highlighting that phlorizin treatment leads to a marked increase in the percentage of the tracer excreted into the bladder (reaching ~35% at 65 min) compared to control (~7%). These visuals demonstrate the role of SGLTs in intestinal glucose absorption and renal reabsorption.

This medical anatomical diagram illustrates the distribution of Sodium-Glucose Co-transporter (SGLT) 1 and 2 receptors throughout the human Central Nervous System (CNS). The diagram uses a lateral view of the brain with numbered black circles corresponding to eight specific anatomical regions: (1) cerebral cortex pyramidal cells, (2) Purkinje neurons, (3) hippocampus, (4) hypothalamus, (5) microvessels, (6) amygdala, (7) periaqueductal gray, and (8) dorsomedial medulla. SGLT1 receptors are represented by red oval labels, while SGLT2 receptors are indicated by green oval labels. The visualization shows that SGLT1 is distributed in regions 1, 2, 3, 4, and 5. SGLT2 expression is depicted in regions 4, 5, 6, 7, and 8. The diagram highlights the co-localization of both receptor types in the hypothalamus (4) and cerebral microvessels (5), providing neuroanatomical context for the physiological roles of SGLT transporters and the potential therapeutic targets for SGLT2 inhibitors in neurological health and glucose metabolism.

This medical anatomical diagram illustrates the distribution of Sodium-Glucose Co-transporter (SGLT) 1 and 2 receptors throughout the human Central Nervous System (CNS). The diagram uses a lateral view of the brain with numbered black circles corresponding to eight specific anatomical regions: (1) cerebral cortex pyramidal cells, (2) Purkinje neurons, (3) hippocampus, (4) hypothalamus, (5) microvessels, (6) amygdala, (7) periaqueductal gray, and (8) dorsomedial medulla. SGLT1 receptors are represented by red oval labels, while SGLT2 receptors are indicated by green oval labels. The visualization shows that SGLT1 is distributed in regions 1, 2, 3, 4, and 5. SGLT2 expression is depicted in regions 4, 5, 6, 7, and 8. The diagram highlights the co-localization of both receptor types in the hypothalamus (4) and cerebral microvessels (5), providing neuroanatomical context for the physiological roles of SGLT transporters and the potential therapeutic targets for SGLT2 inhibitors in neurological health and glucose metabolism.

Finding Sources
I now have comprehensive information. Here is the full, detailed answer:

Why ORS Concentration Must Match Blood Osmolarity

The Core Problem: Osmosis at the Gut Wall

Normal blood osmolarity is 285-295 mOsm/L. The small intestinal lumen is in constant osmotic dialogue with the blood. Water moves passively across the intestinal epithelium following osmotic gradients - it goes where solute concentration is higher. This is why the tonicity of whatever you drink profoundly affects whether water is absorbed into the body or pulled back out into the gut.

The Physiological Mechanism: SGLT1 Cotransport

The secret behind ORS is not just osmolarity - it's the glucose-sodium cotransporter (SGLT1). As Yamada's Textbook of Gastroenterology explains:
"The major process for the absorption of nutrients, such as glucose, is cotransport with Na+ - through the sodium-glucose cotransporter, SGLT1. The entry of these solute molecules draws water across the epithelium... Direct measurements indicate that there is cotransport of 210-260 water molecules per 1 glucose molecule. It has been estimated that SGLT1 absorbs 8-9 liters of water each day from the small intestine."
  • Yamada's Textbook of Gastroenterology, 7th ed.
Each SGLT1 cycle moves 2 Na⁺ ions + 1 glucose + ~210-260 water molecules from the gut lumen into the enterocyte. This is an active, carrier-mediated process that functions even during diarrhea (unlike many other transport mechanisms that are disrupted by enterotoxins like cholera toxin).
This is why ORS works even in cholera: the Na⁺-glucose cotransport pathway remains intact even when cyclic AMP-driven Cl⁻ secretion is maximal.

What Happens If Osmolarity Is Wrong?

ORS TypeOsmolarityProblem
Too hypertonic (e.g., plain sugar water, sports drinks)>300 mOsm/LHigh solute load in the lumen draws water OUT of the bloodstream into the gut by osmosis, worsening diarrhea and dehydration
Too hypotonic (e.g., plain water)~0 mOsm/LNo glucose/Na⁺ to drive SGLT1 cotransport; water poorly absorbed; risk of hyponatremia
Correct reduced-osmolarity ORS245 mOsm/LSlightly hypotonic relative to blood; provides just enough glucose + Na⁺ to maximally drive SGLT1 without osmotic back-pressure
Rosen's Emergency Medicine states directly:
"Fluids containing glucose and electrolytes provide optimal rehydration due to the cotransport of water across the intestinal lumen. Reduced osmolarity rehydration solution (e.g., WHO ORS 245 mOsm/kg) is associated with a reduced need for unscheduled IV infusions, lower stool volume, and less vomiting. High-glucose solutions have high osmolarity, and pure water has a low osmolarity; thus neither are optimal for water resorption."
  • Rosen's Emergency Medicine

WHO ORS Composition (Reduced-Osmolarity Formula)

ConstituentConcentration (mmol/L)
Na⁺75
K⁺20
Cl⁻65
Citrate10
Glucose75
Total osmolarity245 mOsm/L
The old WHO ORS was 331 mOsm/L (near-isotonic). The reduced-osmolarity formula (245 mOsm/L) was introduced because it is slightly hypotonic - this creates a small osmotic gradient that actually favors water movement from lumen to blood, while still providing enough Na⁺ and glucose to saturate SGLT1.

Why Isotonic Is Not Ideal Either

You might expect that matching blood osmolarity exactly (295 mOsm/L) would be best. But the logic goes further: a mildly hypotonic solution is preferable because:
  1. It provides a small osmotic "pull" driving water toward the bloodstream
  2. It reduces luminal fluid retention compared to an isotonic solution
  3. It lowers total stool output by reducing osmotic secretion back into the lumen
This is why the WHO moved from 331 → 245 mOsm/L, which reduced the need for IV rescue therapy and cut stool volumes in clinical trials.

Summary

The reason ORS osmolarity must be matched to blood osmolarity (and kept mildly hypotonic) is a three-part reason:
  1. Osmotic physics - hypertonic fluids pull water INTO the lumen, worsening dehydration
  2. SGLT1 saturation - just enough glucose + Na⁺ is needed to drive cotransport of ~250 water molecules per cycle; excess glucose raises osmolarity without extra benefit
  3. Net absorption efficiency - a slightly hypotonic ORS creates a favorable osmotic gradient from lumen to blood, maximizing water recovery
Plain water fails because it cannot drive SGLT1. Soda or juice fails because the high sugar content makes it hypertonic. Only a precisely formulated ORS with the right Na⁺:glucose ratio at the right osmolarity takes full advantage of the SGLT1 mechanism that remains intact even in secretory diarrhea.

Ideal time duration to measure body temperature by mercury thermometer when used orally or in armpit

Finding Sources
Searching the Web

mercury thermometer oral axillary temperature measurement duration minutes clinical standard

Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
I now have solid textbook and clinical guideline data. Here is the complete answer:

Mercury Thermometer: Duration for Oral and Axillary Measurement

Standard Time Durations

SiteDurationNormal Reading
Oral (sublingual)3 minutes37.0°C (98.6°F)
Axillary (armpit)5 minutes (some sources cite up to 7-10 min)36.4-36.7°C (97.6°F)
Rectal3 minutes37.5°C (99.5°F)

Why the Times Differ

Oral (3 minutes) The sublingual pocket (under the tongue, toward the back) is richly vascularized by the lingual artery. It closely reflects core body temperature, and mercury equilibrates quickly with the surrounding mucosa. The probe must be placed in the posterior sublingual pocket with the mouth kept firmly closed - not under the front of the tongue, which is cooler and gives false-low readings.
  • Roberts and Hedges' Clinical Procedures in Emergency Medicine notes that the sublingual pocket should be used with the mouth closed, and oral electronic probes take up to 3 minutes.
  • One study at high ambient temperatures timed oral mercury thermometers for 5 minutes to ensure full stabilization, noting that "previous literature reported stabilisation of temperature often takes over 3 minutes" in some conditions.
Axillary (5 minutes minimum) The axilla is an external body surface with several physiological disadvantages:
  • Less direct blood supply compared to the sublingual mucosa
  • Exposed to ambient air, so thermometer equilibration is slower
  • Temperature is affected by room temperature, sweating, and arm position
  • The axilla reads 0.5-1°C lower than core temperature
Because of this slower equilibration, the thermometer needs more time - classically 5 minutes, and some patient education guidelines cite 7-10 minutes for accuracy in children. The arm must be held firmly adducted (pressed against the chest) throughout.

Why Axillary Is Less Reliable

Roberts and Hedges' Clinical Procedures in Emergency Medicine explicitly states:
"Axillary and tactile temperature assessments have been demonstrated to be unreliable and insensitive. They should not be used as screening methods for core temperature abnormalities in the ED."
The axillary site is considered a peripheral approximation, not a true core temperature. It is best used when other sites are inaccessible (e.g., in young infants where rectal is preferred, or when oral is not feasible).

Important Precautions for Oral Measurement

Wait 15-30 minutes before taking oral temperature if the patient has:
  • Had hot or cold drinks or food
  • Smoked
  • Chewed gum
  • Done strenuous exercise
  • Recently been breathing through the mouth
Oral measurement is contraindicated in:
  • Children under 5 years (can't hold thermometer safely)
  • Confused, uncooperative, or drowsy patients
  • Patients with recent oral surgery
  • Patients with a history of seizures

Summary

RouteTimeKey reason
Oral3 minRichly vascularized sublingual mucosa equilibrates faster
Axillary5 min (min)Peripheral, air-exposed site equilibrates slowly; some authorities recommend up to 7-10 min
The difference comes down to blood supply and thermal isolation - the mouth surrounds the thermometer with warm, perfused mucosa on all sides, while the armpit is only partially enclosed and takes longer to build up the thermal "pocket" needed for an accurate reading.
This is a shared conversation. Sign in to Orris to start your own chat.